Pas1 candidate 1 (Pas1c1) gene (also named Lmna-rs1) was found to encode two alternatively spliced mRNA transcripts (i.e. Pas1c1-Va and Pas1c1-Vb). In this study, we identified three additional mRNA transcripts encoded by the Pas1c1 gene, which were designated as Pas1c1-Vc, Pas1c1-Vd, and Pas1c1-Ve, respectively. Similar to Pas1c1-Vb, the newly identified transcripts were only expressed in mouse lung tissues from strains carrying the Pas1-susceptible (Pas1/s) allele. Pas1c1 transcripts were also detected in heart, testis, or brain but not in liver, spleen, or kidney. An 11-nucleotide polymorphism was found within the 3 0 -acceptor splice site of exon 8, which cosegregates with mouse strain Pas1 alleles and may underlie the strain-specific exon 8 skipping. We also found that ectopic expression of the Pas1c1-Va and Pas1c1-Vb in COS7 and NIH3T3 cells exhibited distinct intracellular distributions. These results support that Pas1c1 as a candidate for the Pas1 locus and the strain-specific isoforms may have differential effects on cell proliferation.
Lung cancer is the leading cause of cancer death in the US (Minna et al., 2002) . Increasing evidence suggest that genetic susceptibility and gene-environment interactions play a major role in the induction of lung cancer (Minna et al., 2002) . Inbred mouse models offer an effective means of identifying candidate lung cancer susceptibility loci (Malkinson, 1989) . Inbred strains show widely different susceptibilities to both spontaneous and chemically induced lung tumor formation (Malkinson, 1989) . Linkage studies using (A/J Â C3H/ HeJ) F2 mice mapped a major lung tumor susceptibility locus, named pulmonary adenoma susceptibility 1 (Pas1), to the distal region of mouse chromosome 6 (Gariboldi et al., 1993) . Pas1 accounted for approximately 50% of lung tumor phenotypic variance (Devereux et al., 1994; Festing et al., 1994; Manenti et al., 1995; Lin et al., 1998) . We have previously narrowed Pas1 locus to a B500-kb region near K-ras using Pas1 congenic mice strategy (Zhang et al., 2003) . There are six candidate genes identified in this refined region (Figure 1a) . Las1 (lung adenoma susceptibility 1) and K-ras2 were found to be candidates for Pas1 because of their allele-specific effects on cell proliferation and lung tumor development (Zhang et al., 2003) .
We previously reported another candidate gene named the Pas1 candidate 1 (Pas1c1) gene, which encodes a 413-amino-acid protein and has an intermediate filament tail (IF-tail) domain at its C-terminus . This gene was designated Lmna-rs1 for Lamin A-related sequence 1 due to its moderate protein sequence similarity (25-37%, refer to Unigene cluster Mm.348001) with Lamin family proteins (Manenti et al., 2004) . We identified two alternatively spliced transcripts and two amino-acid polymorphisms for the Pas1c1 gene . Interestingly, the transcript expression pattern and amino-acid polymorphisms were to cosegregate with mouse strain Pas1 alleles . The purpose of this study was to further examine the candidacy of Pas1c1 as the Pas1 gene and to determine if these alternatively spliced transcripts contribute to differential cellular functions.
In our previous study, we identified two Pas1c1 alternatively spliced transcripts based on the sequence of Riken full-length cDNA AK016641 . We designated the longer transcript, which contains the 40-amino-acid exon 8 as Pas1c1-Variant a (Pas1c1-Va). The short transcript, which lacks exon 8, was designated as Pas1c1-Variant b (Pas1c1-Vb). Data mining in the NCBI genomic databases revealed that two Riken full-length cDNAs, that is, Ak052206 and Ak035947, were likely to be transcript isoforms of Ak016641 based on their sequence similarities. Ak016641, Ak052206, and Ak035947 have different 5 0 -end and 3 0 -end nucleotide sequences. Multiple primers were designed based on Ak052206 and Ak035947 cDNA sequences (Table 1) . We purchased various strains of mice from Jackson Laboratory (Bar Harbor, ME, USA). Genomic DNA of inbred mouse strains was prepared from tails. A tail clipping from each strain was homogenized and incubated overnight at 371C in lysis solution (pronase 0.4 mg/ml, 10% sodium dodecylsulfate (w/v), 10 mM Tris, 400 mM NaCl, and 2 mM EDTA) followed by saturated NaCl extraction, precipitation with ice-cold 100% alcohol, and washed twice with 70% alcohol. Total RNA extraction was performed using TRIzol reagent according to the manufacturer's protocol (Life Technologies, Gaithersburg, MD, USA). The quality of the isolated RNA was assessed by absorbance at 260 nm, the A260/A280 ratio, and electrophoresis on Pas1c1 is a candidate Pas1 gene M Wang et al 1% agarose/formaldehyde gels that indicated the intensity and integrity of the 28S and 18S bands. Total RNA (2 mg) was used in a reverse transcription reaction to synthesize the first strand cDNA using oligo-dT primer. For detecting the new alternative transcripts, reverse transcription-polymerase chain reaction (RT-PCR) experiments were performed using oligo primers and cDNA samples prepared from mouse lung and other organs. The specific primer sets were designed based on the Riken cDNA sequences Ak016641 (GI: 12855487), Ak052206 (GI: 26342445), and Ak035947 (GI: 26084919) ( Table 1 ). The reaction profile consisted of one cycle at 951C for 5 min, followed by 40 cycles at 941C for 45 s, 581C for 45 s, and 721C for 1 min 30 s. The PCR products were resolved in 2% ethidium bromide-stained agarose gels and visualized under UV irradiation. Using RT-PCR assays followed by direct sequencing, we confirmed the expression of Ak052206 transcripts in mouse lung tissue ( Figure 2 ). However, Ak035947 was not expressed in lung tissues (data not shown). Direct sequencing of PCR products derived from the Ak052206 cDNA identified three new Pas1c1 transcript isoforms. Next, we determined if there is strain-and tissuespecific expression of Pas1c1 transcripts. As shown in our previous studies and Figure 2a , the transcript Pas1c1-Va was detected in all of the examined mouse lung tissues, while the transcript Pas1c1-Vb was only detected in lung tissues from strains carrying the Pas1/s allele. Significantly, the Ak052206-derived three new transcripts Pas1c1-Vc, Vd, and Ve were only detected in lung tissues from mouse strains carrying the Pas1/s allele similar to the Pas1c1-Vb. Using cDNA samples from several A/J mouse organs (lung, liver, spleen, heart, kidney, brain, and testis), we detected the Ak016641-derived Pas1c1-Va and Vb transcripts at relatively high levels in lung, heart, and testis, with weak signal detected in brain (Figure 2b) . Similarly, the Ak052206-derived Pas1c1-Vc, Vd, and Ve transcripts were also detected in lung, heart, brain, and testis, but not in liver, spleen, or kidney (data not shown).
We previously identified three nucleotide polymorphisms in exon 8 . In this study, we determined the genetic basis for the observed exon 8 skipping in the Pas1c1 gene seen in lung tissues from some mouse strains. Since aberrant pre-mRNA splicing events are frequently caused by mutations in the splice sites (i.e. 5 0 -donor site, 3 0 -accteptor site, and branch site), we examined the intron-exon junction sequences. For detection of 3 0 -acceptor splice site polymorphism, the following primer set was used to amplify 3 0 -acceptor splice site sequence from mouse DNA samples: F, 5 0 -CAATAGCACCGTCGGATGTG-3 0 ; R, 5 0 -CTGGA TCGGAACTTGCTCTG-3 0 . In total, 1.2% agarose gel was used to resolve PCR products. Direct sequencing was used to confirm sequence polymorphism. The branch site was not examined due to its uncertain position. We have identified an 11-bp nucleotide polymorphism in the 3 0 -acceptor splice site (Figure 2c  and d) . Sequencing results from inbred strains indicate that this polymorphism is associated with exon 8 splicing. This result supports the hypothesis that the exon 8 skipping observed in mouse strains is caused by Pas1c1 nucleotide sequence polymorphisms rather than polymorphisms in other spliceosome-specific proteins such as small nuclear ribonucleoproteins (snRNPs).
In order to explore the functional implications associated with Pas1c1 alternative splicing, we 0 . The F primer contains a BamHI restriction site (GGATCC), a Kozac sequence (ATCATGG) and a c-Myc-peptide coding sequence (underlined). The R primer contains an XhoI restriction site (CTCGAG). Purified, restriction enzyme-cut, PCR products were cloned into pCDNA3.1 expression vector (Invitrogen, CA, USA). The ORF sequences were confirmed by direct sequencing in both directions. COS7 cells were transfected with the expression vectors and the empty vector. Strong protein expression of Pas1c1-Va and Vb was detected using anti-myc antibody (Figure 3 ). We used a fluorescence-conjugated anti-myc antibody to examine the cellular location of the protein. Specifically, COS7 cells at 80% confluence in a six-well plate were transiently transfected with empty pcDNA3.1 and myc-tagged Pas1c1-pcDNA3.1 vector using Lipofectamine 2000 (Invitrogen, CA, USA) based on the manufacturer's instructions. After 24 h, the transfected cells were trypsinized and seeded on multiwell chamber slides (Lab-Tek, Nalge Nunc International, NY, USA). After growing for an additional 24 h, the cells were fixed with cold methanol followed by washing three times with PBS. The slides were treated with 1% BSA-containing blocking buffer for 30 min. After washing with PBS, the slides were incubated with FITC-conjugated anti-c-myc antibody (Santa Cruz) overnight to stain myc-tagged Pas1c1 proteins. DNA was counterstained with Vectashield mounting medium with propidium iodide (Vector laboratories, CA, USA). Protein expression was confirmed by Western blot using anti-c-myc antibody (Oncogene, CA, USA). Olympus BX51 fluorescence microscope, Spot RT camera, and Spot software (Diagnostic Instruments, Inc., MI, USA) were used to prepare the photos. Percentage of each typical distribution was calculated by dividing the number of cells with typical cellular distribution with the total number of cells being transfected. Interestingly, we observed a striking Figure 3B ). We have repeated the assay three times and obtained similar results. The Pas1c1-Va protein was detected in the cytoplasm, the nuclear envelope, and the nucleus. The Pas1c1-Vb protein was also detected in the cytoplasm and the nuclear envelope. However, Pas1c1-Vb protein was only weakly detected in the nucleus compared to the Pas1c1-Va protein (1373% for Pas1c1-Vb compared to 8175% for Pas1c1-Va-A/J and 7877% for Pas1c1-Va-B6). Since the only difference between the Pas1c1-Va and Pas1c1-Vb proteins lies in exon 8, this exon appears to play an important role in the determination of Pas1c1-Va and Pas1c1-Vb cellular distribution.
Finally, we performed a colony formation assay to determine differential effects of Pas1c1n alleles on cell proliferation. NIH3T3 cells in six-well plates were transiently transfected with 4 mg of myc-tagged Pas1c1-pcDNA3.1 plasmids and empty pcDNA 3.1 plasmid using Lipofectamine Plus reagent (Invitrogen). The cell culture medium was changed after 4 h. At 24 h after transfection, cells were trypsinized and split into 4 Â 10-cm dishes. G418 selection started on the following There are two lines of genetic evidence to support Pas1c1's candidacy as the Pas1 gene. First, its chromosome location is within our refined Pas1 QTL region (Zhang et al., 2003) . Second, the alternative transcript splicing pattern of the Pas1c1 gene, as well as its aminoacid polymorphisms, cosegregate with mouse strain Pas1 allele status . A recent study has found that expression of this gene is lost in mouse lung tumors (Manenti et al., 2004) , suggesting its potential role in mouse lung tumorigenesis. In addition to Pas1c1-Va and Vb, this study identified three new Pas1c1 transcript isoforms, that is, Pas1c1-Vc, Vd, and Ve. Thus, the Pas1c1 gene encodes a more complex transcript repertoire, which contains at least five transcript isoforms. More importantly, expression of these transcript isoforms in mouse lung tissue was found to correlate with mouse strain Pas1 status.
This study revealed that Pas1c1-Vb, Pas1c1-Vc, Vd, and Ve are only expressed in lung tissues from mouse strains carrying the Pas1/s allele. The mechanism of this strain-selective transcription is unknown. It may be caused either by nucleotide sequence polymorphisms at the Pas1c1 locus or unknown protein polymorphisms from other genetic loci. Although we cannot completely rule out the possibility that other proteins, for example, spliceosome proteins like snRNPs, may be responsible for this event, this strain-selective transcription is more likely caused by nucleotide polymorphisms within the Pas1c1 gene. This hypothesis is supported by the cosegregation with the Pas1 alleles of the three nucleotide polymorphisms previously identified in exon 8 and the 3 0 -acceptor splice site polymorphisms identified in the present study.
The function of the Pas1c1 gene is unknown at present. Sequence similarity analysis revealed that the gene has an intermediate filament tail (IF-tail) domain, with moderate similarities (25-37%) to Lamin family proteins. The present study has shown that the Pas1c1 gene is expressed in lung, heart, brain, and testis but not in liver, spleen, or kidney, suggesting potential organ-specific functions for this gene. Interestingly, the cellular distributions of the ectopic expressed Pas1c1-Va and Vb proteins were clearly different. Both types of proteins could be detected in cytoplasm and nuclear envelope, but the Pas1c1-Va protein was much more abundantly distributed in nuclei compared to the Pas1c1-Vb. Since the only difference between these two types of proteins is that the Pas1c1-Va retains the exon 8 while the Pas1c1-Vb does not, we hypothesize that the exon 8 may play an important role in nuclear translocation of Pas1c1 proteins.
Localization of the Pas1c1 proteins to the nuclear envelope suggests a potential function of this gene since it has been reported that the Lamin A protein is preferentially (if not exclusively) localized in nuclear lamina, a protein network underlying the inner nuclear membrane (Eriksson et al., 2003; Favreau et al., 2004; Lammerding et al., 2004) . Its mutations or deficiency undermined stability of the nuclear membrane, contributed to apoptosis, and caused genetic diseases (Eriksson et al., 2003; Favreau et al., 2004; Lammerding et al., 2004) . Not surprisingly, we found that the strainspecific expression of the Pas1c1 gene transcripts may lead to differential functional effects on cell proliferation. Transient transfection of NIH3T3 cells with Pas1c1 expression vectors showed differential gene effects of these isoforms on cell growth in the colony formation assay. Further systematic function analyses using transgenic and knockout strategies of this and other candidates of Pas1 are being pursued.
